Cabaletta Bio (CABA) Payables (2018 - 2025)
Cabaletta Bio (CABA) recorded quarterly Payables of $6.6 million in Q4 2025, down 19.73% quarter-over-quarter from $8.3 million in Q3 2025, and up 34.8% on a YoY basis from $4.9 million in Q4 2024.
Cabaletta Bio (CABA) Payables (2018 - 2025) Analysis & Trends
Cabaletta Bio's Payables history runs 8 years deep, the most recent figure standing at $6.6 million for Q4 2025.
- In Q4 2025, Payables rose 34.8% year-over-year to $6.6 million; the TTM figure through Dec 2025 stood at $6.6 million (up 34.8% YoY), while the FY2025 annual figure was $6.6 million, up 34.8% from the prior year.
- Payables was $6.6 million for Q4 2025 at Cabaletta Bio, down from $8.3 million in the prior quarter.
- In the past five years, Payables ranged from a high of $8.3 million in Q3 2025 to a low of $1.3 million in Q1 2021.
- Historically, Payables has averaged $3.9 million across 5 years, with a median of $3.8 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Payables tumbled 39.78% in 2024, then soared 279.22% in 2025.
- A 5-year view of Payables shows it stood at $2.3 million in 2021, then rose by 5.57% to $2.5 million in 2022, then surged by 84.61% to $4.5 million in 2023, then climbed by 8.27% to $4.9 million in 2024, then surged by 34.8% to $6.6 million in 2025.
- The last three Payables figures came in at $6.6 million (Q4 2025), $8.3 million (Q3 2025), and $7.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.69 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | Cabaletta Bio | 151.84 Mn | 18.24 Mn | - | 6.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.64 Mn |
| Sep 30, 2025 | 8.27 Mn |
| Jun 30, 2025 | 7.19 Mn |
| Mar 31, 2025 | 6.49 Mn |
| Dec 31, 2024 | 4.92 Mn |
| Sep 30, 2024 | 2.18 Mn |
| Jun 30, 2024 | 4.22 Mn |
| Mar 31, 2024 | 5.84 Mn |
| Dec 31, 2023 | 4.55 Mn |
| Sep 30, 2023 | 3.62 Mn |
| Jun 30, 2023 | 2.34 Mn |
| Mar 31, 2023 | 3.96 Mn |
| Dec 31, 2022 | 2.46 Mn |
| Sep 30, 2022 | 1.33 Mn |
| Jun 30, 2022 | 2.45 Mn |
| Mar 31, 2022 | 3.91 Mn |
| Dec 31, 2021 | 2.33 Mn |
| Sep 30, 2021 | 1.71 Mn |
| Jun 30, 2021 | 2.37 Mn |
| Mar 31, 2021 | 1.27 Mn |